Delivery Order SPE2DB24D1201-SPE2DB25FJEFX
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 2, 2025, for the supply of Descovy 200-25 mg tablets in quantities of 30 units. This non-competitive delivery order, valued at $13,063.67 with firm fixed pricing, represents a pharmaceutical procurement under the agency's medical supply chain operations. The contract specifies a place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters, and...
- The Defense Logistics Agency awarded a $44,543.69 delivery order to AmerisourceBergen Drug Corp on July 22, 2025, for the supply of Descovy 200-25 mg tablets in quantities of 30 units. This is a firm fixed-price delivery order with no set-aside designation, reflecting a competitively awarded contract. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of July 23, 2025. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $38,825.06 to AmerisourceBergen Drug Corp for the supply of Descovy 200-25 mg tablets in quantities of 30 units. This is a firm fixed-price delivery order with no set-aside designation, executed on September 16, 2025, with an ultimate completion date of September 17, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under a larger...
- The Defense Logistics Agency awarded a $39,811.80 delivery order to AmerisourceBergen Drug Corp on September 24, 2025, for the supply of Descovy 200-25 mg tablets in quantities of 30 units. This is a firm fixed price, competitively awarded contract with no set-aside designation and a completion date of September 25, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order valued at $13,660.97 to AmerisourceBergen Drug Corp for the supply of Descovy 200-25 mg tablets in quantities of 30 units. This competitively awarded, firm fixed-price delivery order was issued on August 5, 2025, with an ultimate completion date of August 6, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order valued at $17,222.83 to AmerisourceBergen Drug Corp for the supply of Descovy 200-25 mg tablets in quantities of 30, with delivery to the company's corporate office location in Conshohocken, Pennsylvania. This competitively awarded, firm fixed price delivery order was issued on March 18, 2025, with an ultimate completion date of March 19, 2025. The contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order valued at $48,221.18 to AmerisourceBergen Drug Corp for Descovy 200-25 mg tablets in quantities of 30 units. This competitively awarded, firm fixed-price delivery order was executed on August 20, 2025, with an ultimate completion date of August 21, 2025. The product will be supplied from AmerisourceBergen's corporate office located in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a $8,416.97 delivery order to AmerisourceBergen Drug Corp on September 19, 2025, for the supply of Descovy 200-25 mg tablets in quantities of 30. This is a firm fixed price, competitively awarded contract with a completion date of September 22, 2025, and represents a child order under AmerisourceBergen's larger pharmaceutical supply agreement. The order will be fulfilled from the vendor's operations in Conshohocken, Pennsylvania. This delivery order is issued...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $12,027.97 to AmerisourceBergen Drug Corp for the supply of Descovy 200-25 mg tablets in quantities of 30 units. This firm fixed-price contract, awarded on June 20, 2025, represents a competitive procurement with no set-aside designation and carries an ultimate completion date of June 23, 2025. The place of performance is listed as the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $14,184.02 to AmerisourceBergen Drug Corp for the supply of Descovy 200-25 mg tablets in quantities of 30 units. This competitively awarded, firm fixed-price delivery order was issued on August 6, 2025, with an ultimate completion date of August 7, 2025. The product will be performed and delivered from AmerisourceBergen's facility in Conshohocken, Pennsylvania. As a major pharmaceutical distributor, AmerisourceBergen serves as...
- SPE2DB24D1201Indefinite Delivery Contract
- SPE2DB24D1201-SPE2DB25FJEFXDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $45,568.20 to AmerisourceBergen Drug Corp for the supply of Descovy 200-25 mg tablets in units of 30, with an ultimate completion date of September 18, 2025. This is a firm fixed price contract with no set-aside designation, competitively awarded to the prime contractor. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.9 billion comprehensive global pharmaceutical support vehicle running through December 2026 that enables the company to supply a broad range of pharmaceutical products and medical commodities to support military healthcare programs. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal medical procurement vendor that serves the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The company's federal contract portfolio demonstrates extensive experience delivering diverse pharmaceutical products including brand-name and generic medications, vaccines, and specialized medical supplies across multiple therapeutic domains. The DLA Troop Support Medical contract under which this delivery order was issued represents a flexible vehicle for fulfilling pharmaceutical needs across military health systems globally, with the DLA planning to establish additional Pharmaceutical Prime Vendor Global Program Generation V regional contracts involving multiple contractors in the future.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $45.6k | 9/17/25 |